- Home
- Clinical Trials
Androgenetic Alopecia Areata Studies Sydney DH
Androgenetic Alopecia Studies
Darlinghurst Sydney
We’re currently looking for adults aged 18 to 65 who are experiencing androgenetic alopecia (AGA), also known as pattern hair loss, to take part in The Headline Trial.
Hair loss is common and can affect both men and women. This clinical study is investigating new approaches that may help shape future treatment options.
You don’t need a formal diagnosis to get started. If you think you may have AGA, you can begin with a quick pre-screen. This helps us assess whether you may meet the initial study requirements. Completing the pre-screen doesn’t guarantee enrolment, but it’s an important first step in seeing whether the study may be suitable for you.
By getting involved, you’ll be contributing to research that aims to improve future options for people affected by hair loss.
Description
What to expect
Study details
Ages
Adults aged 18 to 65
Duration
Varies
Compensation
You will be well compensated for any study related costs
Eligibility Criteria
To join this study, here’s what we’re looking for
- Weigh over 60kg
- Are experiencing male or female pattern hair loss
- Men: thinning at the crown or a receding hairline
- Have had hair loss for 12 months or more
- Are not experiencing sudden or unexplained shedding
Other criteria applies. A member of our team will check if this study is a good fit for you.
Locations
Description
Androgenetic alopecia, commonly known as male or female pattern hair loss, is the most common form of hair loss and affects millions of men and women worldwide. It is a gradual condition that alters the normal hair growth cycle, leading to progressive thinning of the hair on the scalp. In men, this often appears as a receding hairline or thinning at the crown, while women typically experience diffuse thinning across the top of the scalp.
Although it does not impact physical health, it can significantly affect confidence, self-image, and emotional wellbeing, making it a deeply personal and often distressing condition.
Current treatments for Androgenetic alopecia include topical solutions and oral medications designed to slow hair thinning or stimulate regrowth. While these therapies can be effective for some individuals, results vary, and ongoing use is usually required to maintain benefits.
What to expect
Momentum conducts clinical research studies that explore potential new treatments designed to ease Androgenetic Alopecia symptoms. Register your interest now and find out if one of our research studies is a good fit for you.
All study treatments are free of charge and participants are paid for any study related costs.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.